Aminolevulinic acid and photodynamic combination therapy in the treatment of actinic keratoses: caring for the patient

Dermatol Nurs. 2007 Feb;19(1):31-4, 39.

Abstract

Combination therapy with 5-aminolevulinic acid and photodynamic therapy is fast becoming the treatment of choice in treating precancerous skin lesions such as actinic keratoses. Judicious care is recommended in treating the patient prior to, during, and after treatment to ensure optimal results while avoiding misunderstandings, and potentially troublesome adverse effects. The biologic mechanism involved with 5-aminolevulinic acid and photodynamic therapy, as well as the patient care recommended prior to and throughout the therapy, are outlined.

Publication types

  • Review

MeSH terms

  • Aminolevulinic Acid / adverse effects
  • Aminolevulinic Acid / metabolism
  • Aminolevulinic Acid / therapeutic use*
  • Heme / biosynthesis
  • Humans
  • Keratosis / drug therapy*
  • Keratosis / etiology
  • Keratosis / pathology
  • Nurse's Role
  • Nursing Assessment
  • Photochemotherapy* / adverse effects
  • Photochemotherapy* / methods
  • Photochemotherapy* / nursing
  • Photosensitizing Agents / adverse effects
  • Photosensitizing Agents / metabolism
  • Photosensitizing Agents / therapeutic use*
  • Precancerous Conditions / etiology
  • Precancerous Conditions / prevention & control
  • Protoporphyrins / metabolism
  • Skin Care / methods
  • Skin Care / nursing
  • Skin Neoplasms / etiology
  • Skin Neoplasms / prevention & control
  • Ultraviolet Rays / adverse effects*

Substances

  • Photosensitizing Agents
  • Protoporphyrins
  • Heme
  • Aminolevulinic Acid